Anouar Alami studied Chemistry at Montpellier II University, France and He received his PhD in 1991. He then joined in 1992 the department of chemistry at the Faculty of Sciences Dhar El Marhaz, Sidi Mohamed Ben Abdellah University (Fez, Morocco). He obtained his state doctorate thesis degree in Organic Chemistry in 1997 at SMBAU. In parallel to all his responsibilities (Head of Department of Chemistry, Responsible for the doctoral training "Bioactive Molecules, Health and Biotechnologies", Director of the Laboratory of organic chemistry, Coordinator of the Bachelor's degree program "Chemistry Sciences"), he had prepared a DEUG (2008) and a License (2010) in Private Law in French and a Master in Economics and Management (2013) at the Faculty of Economics, Law, and Social Sciences of Fez. Concerning the scientific research side, He had published more than 85 research articles indexed in several databases (Scopus, Web of science, Elsevier, Eric, IMIST…).

Dr.Diane Williamson is a Dstl Fellow in Immunology, based at Porton Down. She has worked in R&D (starting in veterinary vaccinology and moving to human vaccines and therapies for serious pathogens) for 30 years. She has published extensively, on the theme of prophylaxis and therapy of serious human diseases for biodefence and emerging pathogens and has worked in the R& D pipeline from discovery to translation to the clinic. Additionally she is currently a Fellow of the Royal Society of Biology and of the Royal College of Pathology and has served as a Trustee and national Education secretary of the British Society for Immunology.

Ali Karami is currently working as a professor of Molecular Biology (Medical Biotechnology), Genetic Engineering and Bioinformatic Research Center of Molecular Biology, Baqyiatallah University of Medical Sciences. Tehran-IRAN. He is working and teaching in areas like Molecular Biotechnology, Rapid Molecular Detection of Infectious Diseases, like PCR, RT PCR, Microarray, Rapid Immunological detection methods, Point of care for detections, Surveillance and molecular Epidemiology of infectious diseases, Novel Vaccines like Recombinant and DNA vaccine and production of Recombinant Protein for Prevention, Detection and Treatment. Other areas that he has been working since last 25 years are Bioinformatics, Genomics, proteomics and System Biology, Biosafety, Biosecurity, Medical Bio-defence, Bioethics and BWC convention.

Antibiotic Resistance, soil bacteria

Zlatko Dembic is a Professor of Immunology, Cell-Biology and Microbiology at University of Oslo. He has been working in science at various institutions in Academia (Medical Faculty, Zagreb, Croatia; Max-Planck Institute for Immunogenetics, Tubingen, Germany; Basel Institute for Immunology, Switzerland; Institute of Immunology, Oslo, Norway) and industry (Roche, Switzerland). He has his expertise in molecular biology shown by over 100 publications to date and a monograph about cytokines in immunology. He is co-inventor of the US patent (Roche) covering the production and use of etanercept (Enbrel), which is a successful (anti-TNF) biological used to treat several autoimmune diseases including rheumatoid arthritis. He was the president of the Norwegian Society for Immunology and Editor-in-chief of the Scand J Immunol (at present, Associate Editor). He is a Visiting Professor of Medicine at medical school in his hometown Rijeka (Croatia).

Immunology, Cell-Biology and Microbiology

Peter Timms is Professor of Microbiology at the University of Sunshine Coast in Queensland, Australia. He is a nationally and internationally renowned microbiologist with specific expertise in the area of Chlamydia. His laboratory is acknowledged as the leading Australian laboratory and one of the leading groups internationally working on all aspects of chlamydial infections. His research group of 12 staff and students is developing vaccines and new diagnostics for chlamydial diseases in humans and animals as well as an improved understanding of chlamydial genomics, cell biology and pathogenicity. The group is widely acknowledged for its major contributions to chlamydial infections in koalas and other wildlife, including the development of a vaccine for koalas. He has published over 250 papers, reviews and book chapters in peer-reviewed international scientific journals.

Chlamydial Infections, Cell biology, Pathogenicity

Professor Paul Van Buynder is a Public Health physician on the Gold Coast and holds an appointment as a Professor in the School of Public Health at Griffith University in Queensland. He is the Immediate pat president of the Australian Immunisation Coalition. He has held previous senior public health positions in a number of Australian states, at the Centre for Infections in the United Kingdom and in two Canadian provinces. He has held personal appointments on the Influenza sub-committees of National Advisory committees in three continents.

vaccine effectiveness studies, and the evaluation of programs and marketing to maximise vaccine coverage

Professor Paul Van Buynder is a Public Health physician on the Gold Coast and holds an appointment as a Professor in the School of Public Health at Griffith University in Queensland. He is the Immediate pat president of the Australian Immunisation Coalition. He has held previous senior public health positions in a number of Australian states, at the Centre for Infections in the United Kingdom and in two Canadian provinces. He has held personal appointments on the Influenza sub-committees of National Advisory committees in three continents. He has over 50 publications.

Vaccine effectiveness studies, and the evaluation of programs and marketing to maximise vaccine coverage

Epidemology, S. pneumoniae

Hanadi Salman Al-Salmi Recently holds the position of Assistant Director of Infection Control and Hospital in Epidemiology at King Faisal Specialist Hospital and Research Center, and a member of the Makkah Region HealthCare Council, Team Leader PCI Standard for Joint Commission Accreditation. At the same time she has done 5 publications in collaboration with different departments and personnel such as: Risk Factors for Middle East Respiratory Syndrome Coronavirus Infection among Healthcare Personnel, CDC, EID Journal, Volume 22, November 2016, Risk Factors for Middle East Respiratory Syndrome Coronavirus Infection Among Healthcare Personnel" to the New England Journal of Medicine,Itemizing the Bundle: Achieving and Maintaining “ZERO” Central Line-Associated Bloodstream Infection For Over A Year in a Tertiary Care Hospital in Saudi Arabia, AJIC and Taking Compliance in Hand – Hand Hygiene and Importance of Education, EMH Magazine UK.

Infectious diseases

Edgar M. Carvalho is Professor of Medicine of the Federal University of Bahia Medical School and Senior Investigator of the Oswaldo Cruz Foundation. He is a clinic immunologist with expertise in the pathogenesis, Immunology and therapy of tropical diseases mainly in leishmaniasis, helminthic infections and Human T cell lymphotropic virus type 1 (HTLV-1 infection). He has developed the facilities to follow a large amount of patients as well as carriers in the endemic areas of the Schistosoma mansoni and Leishmania braziliensis infection and in a HTLV-1 clinic at the University Hospital of Federal University of Bahia.

Imunopathogenesis, host and parasite interaction

Prof. Eliora Ron serves as Scientific Advisor of BioPetroClean. Prof. Ron served as Scientific Director and Member of Scientific Advisory Committee at MIGAL - Galilee Research Institute LTD. until November 7, 2016. Prof. Ron is a Professor of Microbiology at Tel Aviv University. She serves as the author of more than 150 publications and holds several patents. She serves as Chair of Manja and Morris Leigh for Biotechnology and Biophysics. She serves as President of the Federation of European Microbiological Societies and Federation of Israeli Societies of Experimental Biology. Prof. Ron holds a Ph.D. in Microbiology from Harvard University.

Regulation of gene expression, Bacterial virulence, Use of bacteria to combat pollution

Professor Timms is Professor of Microbiology at the University of Sunshine Coast in Queensland, Australia. He is a nationally and internationally renowned microbiologist with specific expertise in the area of Chlamydia. His laboratory is acknowledged as the leading Australian laboratory and one of the leading groups internationally working on all aspects of chlamydial infections. His research group of 12 staff and students is developing vaccines and new diagnostics for chlamydial diseases in humans and animals as well as an improved understanding of chlamydial genomics, cell biology and pathogenicity. The group is widely acknowledged for its major contributions to chlamydial infections in koalas and other wildlife, including the development of a vaccine for koalas. He has published over 250 papers, reviews and book chapters in peer-reviewed international scientific journals.

Chlamydial infections and diagnosis

Luis Ulloa is Associate Professor of Rutgers - New Jersey Medical School, USA. His study focuses on innate immune responses to septic and aseptic conditions and their regulation by the nervous system in experimental models of sepsis and hemorrhage/Resuscitation.

Molecular mechanisms of neuronal modulation of the immune system, Bioelectronic immunology,

João R. Mesquita (D.V.M., M.Sc.; Ph.D.) is a Professor at the Polytechnic Institute of Viseu, Veterinary Section, where he teaches topics within Infectious Diseases for more than 10 years. On the past decade he has focused on Virology, where he has published 44 papers in Scopus indexed Journals. He has won several scientific prizes from different societies and conferences, where he has presented numerous oral and poster presentations.

Animal and human virology and Zoonotic viruses

Dr. Muhammad Adeel Hassan Worked as PG Student Fellow in a USAID funded research project under title “Arthropod Functional Genomics: Building Community Resources for Animal Health” from 18-11-2013 to 16-08-2014. Dr. Hassan holds his Ph.D. Veterinary Parasitology and Molecular Biology from Chinese Academy of Agricultural Sciences, Lanzhou Veterinary Research Institute, China. He contributed to establish and develop advance research laboratory assays. Also, he explored new methods and knowledge to enrich scientific community with latest information by teachings, trainings, international presentations and publications. He published many articles in national and international journals like Ticks and Tick-Borne Diseases, Parasites and Vectors, Acta Tropica, Parasitology Research, Journal of Parasitology, Asian Journal of Animal and Veterinary Advances etc. He received many honours like Membership of “The American Society of Parasitologists” , award of laptop from Prime Minister of Pakistan for educational achievements and Outstanding Student Award-2018.

Vector borne diseases, Theileriosis, Babesiosis, Microscopy, PCR, Recombinase polymerase amplification, Cloning, Epidemiology, Genetic diversity, Serological diagnosis,

Strategic and creative consultant in biomedical science, with a parallel career in the Dutch Civil-Military Interaction Command in which he has responsibility for the counter measures in CBNRe threats and (medical) consequence management both in a military and a civilian (terrorism) setting. He was the director of the 2014 & 2016 World Congress of CBRNe Science & Consequence Management in Tbilisi, Georgia. He works internationally as consultant or scientific supervisory board member for several medical and biotech companies, merely involved in biodefense, clinical diagnostics and therapies. He is also visiting professor for Punjab University in Pakistan and Rhein-Waal University in Germany and visiting professor at the University of Rome Tor Vergata. He has finished both his studies in Medicine and in Biochemistry at the University of Groningen in The Netherlands and has extensive practical experience in cell biology, immuno-haematology, biodefense and transfusion medicine. His natural business acumen and negotiation competence helps to initiate new successful businesses, often created out of unexpected combinations of technologies. His thorough understanding of abstract science combined with excellent skills in the communication of scientific matters to non-specialists, helps him with strategic consulting at top level management.

Ebola

Dr. Ghada Al Qassim is a consultant pediatric emergency medicine and a chairperson of emergency medicine department, Royal Medical Services, Kingdom of Bahrain. She was the first Bahraini female graduate with pediatric emergency fellowship from Saudi Council for Health Specialties (SCHS). Dr Al Qassim is currently the president of Bahrain Medical Society (BMS). She is also the first general secretary of the Gulf Federation of Emergency Medicine (GFEM). She is a senior clinical lecturer & examiner in Pediatric Emergency Medicine at the Royal College of Surgeons in Ireland, Bahrain. Also a member in Bahrain National Ambulance Committee.

handling healthcare of patients, Pediatric Emergency Medicine,ailment diagnosis

Dr. Rubén Bueno-Marí finished his Ph.D. in 2010 in the University of Valencia (Spain) and obtained the Special Doctorate Award in the field of Natural Sciences two years later. He is an active member of several scientific associations at national and international level, highlighting his role as current President Elect of the European Mosquito Control Association (EMCA). He is an expert advisor of the Iberoamerican Society of Scientific Information (SIIC) and has published more than 60 scientific publications in journals related with the fields of medical and veterinary entomology, applied zoology, parasitology and public health. He currently cooperates with several universities and other academic institution in superior teaching issues related with his field of expertise (medical entomology, vector control and vector-borne diseases) and is the head of the Department of Research and Development (R+D) of a leading company in environmental health called Laboratories Lokímica.

Vector-borne Diseases, Arbovirus, Zoonoses, Medical Entomology

Dr. Abdulrahman Mohamad is a senior consultant physician in infectious diseases, graduated from faculty of medicine 1996, and holds his master degree from Ein-Shams school of medicine, EGYPT his areas of expertise are clinical pathology , immunology and microbiology, the university is considered the top in Egypt in such specialties, he joined many hospitals as a lab director and when he saw that infectious diseases became a monster terrifying people all over the world , he directed his knowledge and skills to fight them, in the way to achieve that he got his American board of infection control and epidemiology from CBIC to complete his mission in fighting emerging infectious diseases and became the first consultant In a very well-known group of hospitals in the middle east. In the way of seeking perfection, he also earned a double degree in healthcare quality from Stanford university in collaboration with Ein-Shams university recently he is based in KSA building up teams from health care professionals, training them to become experts in fighting infections especially that the region is endemic with corona virus.

clinical pathology, immunology and microbiology

Yousef Nazzal completed his Ph.D. in Environmental Sciences at the M.S.University of Baroda /India. He went on to establish and lead the efforts of Environmental sciences associations and academic programs in Public Sectors and Academic Institutions in the Middle East and North America. For the past 30 years, he served in different academic and administrative positions in Yarmouk University, King Saud University, Salalah Education College, Abu Dhabi University, Zayed University and University of Ontario Institute of Technology. He is the author or inventor on more than 120 papers and patents. Presently the Chair, Dept. of Life and Environmental Sciences/Zayed University in UAE.

environmental and hydrology

Dr. Ali was a House Officer in Hospitals of Sohag University.He was a Resident of (Tropical medicine and Gastroenterology) for three years .Clinical demonstrator and assistant lecturer of Tropical medicine and Gastroenterology at Sohag University.He is also a Lecturer of Tropical medicine and Gastroenterology ,South Valley University and Ass professor of Tropical medicine and Gastroenterology ,South Valley University.Dr. Ali is the Head of Tropical medicine and Gastroenterology department , South Valley University and also a Member of the European Society of Liver Diseases (EASL).He is working as a Deputy Head of Quality Unit, Qena Faculty of Medicine, South Valley University and a Member of the Graduate Studies Committee, Qena Faculty of Medicine, South Valley University.Member of Education Affairs Committee, Qena Faculty of Medicine, South Valley University.

Tropical Medicine, Liver Diseases

Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). His researches have been concerned with the characterization of specific virus-induced tumour antigens, which were the "finger-prints" left behind in human cancer. Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.

Clinical and laboratory applied, Virology basic and diagnostic, Viral Oncology, Immunology clinical practice,Vaccines.

Graduated from Medicine School, Sassari University, Italy (1980) and Specialized in Infectious Diseases (1983), Allergology and Clinical Immunology (1986), “La Sapienza University”, Rome, Italy. Researcher at the Department of Infectious Diseases, “La Sapienza University”, Rome (1981-1992) and Associated Professor of Infectious Diseases at University of Ferrara, Italy (1992-2004). Education at Department de Pathologie Exotique et Maladies Tropicales, Université Claude Bernard, Lyon, France (1988-1996), Groupe Immunité des Muqueuses et Agents Pathogenes, Université Jacques Lisfrang, Saint-Etienne, France (1998-2000), Department de Biotechnologies (1989-1995), Laboratoire des Mycoplasmas and des Chlamydiae, Institut Pasteur, Paris, France (1996-2005); Department of Biological Sciences (Pneumocystis jiroveci Unit, University of Cincinnati, Ohio, USA, 2001. Since 2005 is Full Professor and Chairman of Infectious Diseases, Chief of the Unit of Infectious Diseases and Dermatology at Department of Medical Sciences of the University of Ferrara and Director of the School of Specialization in Infectious and Tropical Diseases. He teaches at the PhD of Molecular Medicine and Pharmacology of the University of Ferrara. Main research interests Diagnosis and therapy of infectious diseases, AIDS-related opportunistic infections, Leishmania infantum, polyomavirus SV-40, Chlamydia and Mycoplasma infections, HBV and HCV infections, Tuberculosis. He has filed an International Patent: Use of terbinafine for the therapeutic treatment of pneumocystosis (United Stated Patent; Application US19950525526 on 1995-09-12; Publication: 1998-02-17) and has contributed to the preparation of molecular diagnostic kits for Chlamydia trachomatis (REALQUALITY RS-CHLAM T, code RQ-S33: Kit for identification and quantification of Chlamydia trachomatis, AB Analytica Advanced Medicine). Scientific activity Carlo Contini has published more than 320 scientific papers and various chapters of Infectious and Tropical Diseases in Italian and international treatises. He has organized a number of Italian and International Conferences of Infectious and Tropical Diseases

Diagnosis and therapy of infectious diseases,AIDS-related opportunistic infections,Leishmania infantum,HBV and HCV infections,Tuberculosis.

Professor Dr Ibrahim El- Bayoumy holds bachelor of medicine and surgery (Tanta faculty of medicine-Egypt,1989),then he earned his master degree in public health, preventive and social medicine (Tanta faculty of medicine-Egypt1996),and MD,PhD in public health, preventive and social medicine 2003 from Tanta faculty of medicine-Egypt and McGill faculty of medicine –Montreal -Canada in division of clinical epidemiology in Royal Victoria hospital through double channel system as scholarship from ministry of education-Egypt. He is Full professor of public health and community medicine in Tanta faculty of medicine Egypt. Now he is working in ministry of health in Kuwait as consultant of public health and preventive medicine. Dr El Bayoumy has published many research works in international journals, he is interested in research in epidemiology of infectious diseases like HIV, tuberculosis, brucellosis and infectious hepatitis, he is interested in epidemiology of chronic diseases like diabetes mellitus and its health economics and pharmacoepidemiology. He is a reviewer of many national and international journals. He has great interest also in childhood obesity and has written a chapter on childhood obesity in a book published by Nova publishers in USA. He has obtained post-graduate Master’s degree is diabetes care and education-Dundee faculty of medicine-Scotland –UK October 2015. He was invited speaker in many international conferences in China. South Korea , Japan and Kuwait

Epidemiology of infectious diseases, Epidemiology of chronic diseases

Dr. Digambar Behera is a Senior Professor and was the Head of the Department of Pulmonary Medicine at the Postgraduate Institute of Medical Education and Research, Chandigarh, an autonomous Institute and Institute of National importance. He was also the Dean (Research) of the Institute. He was also Director of the LRS Institute of Tuberculosis and Respiratory Diseases, now known as the National Institute of Tuberculosis and Respiratory Diseases, New Delhi, another autonomous Institute under the Ministry of Health and Family Welfare, Govt of India for a period of 51/2 years. Dr Behera is an acclaimed Respiratory Physician par excellence, teacher, and researcher of National and International repute, a social worker and has distinguished with exceptional achievements and contributions of innovative nature in the field of Medicine (Respiratory) and has rendered immense service to the public at large and the poor in particular. He is one of the pioneers to start DM super-specialty course in Pulmonary and Critical Care Medicine for the first time in the country in 1989. More than 60 of his students are spread in the country and abroad. He heads a State of the Art Department and specialty, which is a WHO Collaborating Centre for Research & Capacity Building in Chronic Respiratory Diseases. He has led to develop newer investigative procedures like Endobronchial Ultrasound, Medical Thoracoscopy, Stenting. The Department under his guidance is doing maximum number of procedures in an innovative way like radial EBUS, Cryobiopsy. His team has developed guidelines for managing chronic respiratory diseases like COPD and asthma in a resource limited setting, particularly diagnosis and cost-effective treatment and training grass root physicians in handling such cases. He has over 536 scientific publications with 4100 citations with h index of 34 and i10 index of 112. This is exceptionally outstanding academic achievements at any standard. He has authored a Text book of Pulmonary medicine (2 editions), editor-in-Chief of a Text book of Respiratory Medicine. Other books authored by him are Tuberculosis, Bronchial Asthma, lung Cancer and has contributed 42 chapters to various books. His work has been recognized in the form of 28 National and 7 International awards.

Branchial Asthma, Lung Cancer, COPD

Director of Infectious Diseases Unit at "Annunziata" Hospital, Cosenza, Italy

HIV infection & STDs, Bacterial and Fungal Infections,Antibiotics and Antifungal therapy.

Pei-Yong Shi, PhD, is I.H. Kempner Professor of Human Genetics, University of Texas Medical Branch, Galveston Texas, USA. He is also adjunct Professor of Emerging Infectious Diseases at the Duke-NUS Graduate Medical School in Singapore and Honorary Professor at the Wuhan Institute of Virology, Chinese Academy of Sciences. He received his Ph.D. in virology in 1996 from Georgia State University. After postdoctoral training at Yale University, he joined Bristol-Myers Squibb as a Principal Scientist to develop HIV and HCV therapeutics from 1998 to 2000. He then moved to the Wadsworth Center, New York State Department of Health, to study West Nile virus. From 2008 to 2015, he served as Dengue Unit Head and Executive Director to lead drug discovery at Novartis Institute for Tropical Diseases. His group developed the first infectious clone of the epidemic strain of West Nile virus, discovered two RNA cap methylation activities of flavivirus NS5 protein, identified essential RNA elements for flavivirus replication, established various platforms for flavivirus vaccine and drug discovery, and pioneered therapeutics development for dengue virus. He has published over 190 peer-reviewed articles and served as Editor (ACS Infectious Diseases, Journal of General Virology, and Nature Vaccine) and Editorial Board member (Journal of Virology, Virology, and Antiviral Research). He is internationally recognized for his scholar and administrative accomplishments at leading research institution, public health sector, and pharmaceutical industry.

Flaviviral infection, Human Diseases, Drug disovery and vaccines for Viral Infections

He has held important positions in academics (JN Medical college, Aligarh; AIIMS, New Delhi; Sharjah Medical College and Mahatma Gandhi Medical University, Jaipur); industrial research (Ranbaxy New Drug Discovery and Fortis Clinical Research Ltd) Diagnostic labs (Religare SRL Diagnostics and Star Metropolis); tertiary care hospital (JN Medical College, AIIMS and Medanta the Medicity) Public Health (CAREC, PAHO/WHO), Public Health Technology Transfer of PHFI. He has published over 100 research papers in peer reviewed international journals, guided over 40 students for their MD/MS/PhD and is named in 30 international patents. He is also the author of NBT sponsored book published by Churchill Livingstone, Antimicrobials in Laboratory Medicine (2000), Has contributed more than a dozen chapters in different books

Medical Microbiology

Associate Director of Clinical Proteomics Core Dept. of Pathology and Laboratory Medicine University of California Health System USA

Disease Biomarkers for Studies on Tuberculosis (TB)

Jintao Li, female, Professor, Director and Principle Investigator, Institute of Tropical Medicine, Third Military Medical University(TMMU). She got her master degree in molecular biology from Biotechnology Centre, Southwest University in 1996 and then became a faculty in Genetics Department, TMMU and got her Ph.D degree in Immunology Institute, PLA, TMMU in 2000 and became associate professor and then professor later since then till to 2013. From 2011-2012, she worked in Canada as a visiting scientist for one year. Now she has published more than 100 academic papers such as Science Translational Medicine, J.I, E.J.I, etc. and got 5 items of awards. Awards and group menberships 2010 Chongqing Natural Science Prize “Antigen immune response regulation” 2009 First class of Chinese medical award “Antigen protein antigenic properties and Engineering Research” 2005 Chongqing natural science prize “Relationship with the immune response to a protein antigen characteristic” 2003 Excellent graduate doctor in TMMU 1993~1996 University first grade Scholarship 1989~1993 University second grade Scholarship

Tropical Pathogens and Epidemiology, Immunology, Biotechnology & Molecular Biology